(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.01%) $78.37
(0.59%) $2.22
(-0.06%) $2 322.80
(-0.25%) $27.48
(0.09%) $989.30
(0.08%) $0.930
(0.15%) $10.92
(0.06%) $0.800
(0.12%) $91.45
Live Chart Being Loaded With Signals
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases...
Stats | |
---|---|
Dagens volum | 161 222 |
Gjennomsnittsvolum | 163 739 |
Markedsverdi | 10.78M |
EPS | $0 ( 2024-03-29 ) |
Neste inntjeningsdato | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.202 |
ATR14 | $0.0430 (13.71%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-12-07 | Wolf Jeffrey Alan | Buy | 2 843 137 | Stock Option (right to buy) |
2022-12-07 | Smith Edward B Iii | Buy | 101 960 | Stock Option (right to buy) |
2022-12-07 | Prendergast John K A | Buy | 203 921 | Stock Option (right to buy) |
2022-12-07 | Ostrander William L. | Buy | 490 196 | Stock Option (right to buy) |
2022-12-07 | Monahan John J | Buy | 101 960 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 95 transactions |
Buy: 24 129 486 | Sell: 659 541 |
Volum Korrelasjon
NightHawk Biosciences, Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
NightHawk Biosciences, Korrelasjon - Valuta/Råvare
NightHawk Biosciences, Økonomi
Annual | 2022 |
Omsetning: | $5.98M |
Bruttogevinst: | $-420 025 (-7.02 %) |
EPS: | $-1.710 |
FY | 2022 |
Omsetning: | $5.98M |
Bruttogevinst: | $-420 025 (-7.02 %) |
EPS: | $-1.710 |
FY | 2021 |
Omsetning: | $2.11M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-1.410 |
FY | 2020 |
Omsetning: | $2.95M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-1.630 |
Financial Reports:
No articles found.
NightHawk Biosciences,
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. The company has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is headquartered in Morrisville, North Carolina.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.